These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2874450)

  • 1. Side-effects of flunarizine.
    Lancet; 1986 Aug; 2(8504):463-4. PubMed ID: 2874450
    [No Abstract]   [Full Text] [Related]  

  • 2. Movement disorders and depression due to flunarizine and cinnarizine.
    Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
    Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine.
    Meyboom RH; Ferrari MD; Dieleman BP
    Lancet; 1986 Aug; 2(8501):292. PubMed ID: 2874317
    [No Abstract]   [Full Text] [Related]  

  • 4. Flunarizine- and cinnarizine-induced extrapyramidal reactions.
    Micheli F; Pardal MF; Gatto M; Torres M; Paradiso G; Parera IC; Giannaula R
    Neurology; 1987 May; 37(5):881-4. PubMed ID: 3574697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine.
    Capellà D; Laporte JR; Castel JM; Tristán C; Cos A; Morales-Olivas FJ
    BMJ; 1988 Sep; 297(6650):722-3. PubMed ID: 3147743
    [No Abstract]   [Full Text] [Related]  

  • 6. Flunarizine in common migraine: Italian cooperative trial. II. Long-term follow-up.
    Bono G; Manzoni GC; Martucci N; Baldrati A; Farina S; Cassabgi F; De Carolis P; Nappi G
    Cephalalgia; 1985 May; 5 Suppl 2():155-8. PubMed ID: 3893736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine.
    Chouza C; Scaramelli A; Caamaño JL; De Medina O; Aljanati R; Romero S
    Lancet; 1986 Jun; 1(8493):1303-4. PubMed ID: 2872433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side-effects of flunarizine.
    Amery W
    Lancet; 1986 Jun; 1(8496):1497. PubMed ID: 2873303
    [No Abstract]   [Full Text] [Related]  

  • 9. D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study.
    Brücke T; Wöber C; Podreka I; Wöber-Bingöl C; Asenbaum S; Aull S; Wenger S; Ilieva D; Harasko-van der Meer C; Wessely P
    J Cereb Blood Flow Metab; 1995 May; 15(3):513-8. PubMed ID: 7714010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapyramidal and depressive side reactions with flunarizine and cinarizine.
    Mangone CA; Herskovits E
    J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):288-9. PubMed ID: 2703850
    [No Abstract]   [Full Text] [Related]  

  • 11. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
    Negrotti A; Calzetti S
    Mov Disord; 1997 Jan; 12(1):107-10. PubMed ID: 8990063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Double-blind clinical study: flunarizine versus pizotifen in a single nightly dose in hemicrania patients].
    Cerbo R; Casacchia M; Formisano R; Buzzi MG; Boni B; Feliciani M; Grillo G; Cusimano G; Agnoli A
    Riv Neurol; 1985; 55(2):139-46. PubMed ID: 4012191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis.
    Teive HA; Troiano AR; Germiniani FM; Werneck LC
    Parkinsonism Relat Disord; 2004 Jun; 10(4):243-5. PubMed ID: 15120099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonism and other movement disorders in outpatients in chronic use of cinnarizine and flunarizine.
    Fabiani G; Pastro PC; Froehner C
    Arq Neuropsiquiatr; 2004 Sep; 62(3B):784-8. PubMed ID: 15476069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flunarizine: a wide spectrum prophylactic for migraine headache.
    Micieli G; Sances G; Pacchetti C; Trucco M; Magri M; Piazza D
    Int J Clin Pharmacol Res; 1984; 4(3):239-45. PubMed ID: 6490242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine.
    Jhang KM; Huang JY; Nfor ON; Tung YC; Ku WY; Lee CT; Liaw YP
    Eur J Clin Pharmacol; 2017 Jul; 73(7):911-916. PubMed ID: 28386684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilating effect of flunarizine in anesthetized dogs.
    Kato H; Kurihara J; Ishii K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):257-63. PubMed ID: 7224725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of flunarizine in the treatment of tinnitus.
    Hulshof JH; Vermeij P
    ORL J Otorhinolaryngol Relat Spec; 1986; 48(1):33-6. PubMed ID: 3513083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsive properties of cinnarizine and flunarizine in rats and mice.
    Desmedt LK; Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1975 Sep; 25(9):1408-13. PubMed ID: 1242663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo].
    Frenken CW; Nuijten ST
    Fortschr Med; 1984 Mar; 102(12):349-51. PubMed ID: 6370811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.